STELLA, GIULIA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 242
EU - Europa 99
AS - Asia 51
AF - Africa 2
Totale 394
Nazione #
US - Stati Uniti d'America 238
CN - Cina 25
IT - Italia 24
IE - Irlanda 20
SE - Svezia 14
FI - Finlandia 9
SG - Singapore 7
AT - Austria 6
KR - Corea 6
VN - Vietnam 6
GB - Regno Unito 5
UA - Ucraina 5
DE - Germania 4
FR - Francia 4
PL - Polonia 4
HK - Hong Kong 3
MX - Messico 3
IN - India 2
NL - Olanda 2
BE - Belgio 1
CA - Canada 1
JP - Giappone 1
RO - Romania 1
SN - Senegal 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 394
Città #
Ann Arbor 38
Chandler 34
Dublin 20
Fairfield 20
Beijing 13
Woodbridge 12
Houston 11
Torino 9
Ashburn 8
Pisa 8
Dearborn 7
Seattle 7
Wilmington 7
Medford 6
Vienna 6
Cambridge 5
Jacksonville 4
Nyköping 4
Princeton 4
Singapore 4
Villeurbanne 4
Warsaw 4
Buffalo 3
Camden 3
Fremont 3
Hong Kong 3
New York 3
Boardman 2
Dong Ket 2
Mexico 2
Munich 2
Pune 2
Alberton 1
Amsterdam 1
Berlin 1
Brookline 1
Brussels 1
Cantu 1
Chengdu 1
Cuneo 1
Des Moines 1
Guro-gu 1
Hangzhou 1
Hebei 1
Hefei 1
Helsinki 1
Iasi 1
Kunming 1
Leiden 1
Mountain View 1
Nanjing 1
Ottawa 1
Phoenix 1
Raleigh 1
Rome 1
Seoul 1
Shanghai 1
Shenyang 1
Silver Spring 1
Stockholm 1
Taipei 1
Turin 1
Upper Marlboro 1
Wuhan 1
Xian 1
Totale 293
Nome #
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 149
EVALUATION OF DRUG RESPONSES IN NON-TRANSFORMED CELLS CARRYING CANCER ALLELES 106
MET mutations are associated with aggressive and radioresistant brain metastatic non-small-cell lung cancer 89
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 61
Totale 405
Categoria #
all - tutte 1.139
article - articoli 0
book - libri 0
conference - conferenze 270
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.409


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202050 6 2 3 8 3 8 7 2 3 4 3 1
2020/202142 3 4 0 2 3 1 3 4 5 2 2 13
2021/202298 20 10 6 11 1 5 3 5 0 6 19 12
2022/202392 5 9 3 11 5 19 7 7 19 0 6 1
2023/202433 4 2 1 1 1 10 1 0 0 0 7 6
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 405